Sunlamps: Scientific and Regulatory Issues W. Howard Cyr &Sunlamp Working Group. Center for Devices and Radiological Health Regulatory Meeting, Baltimore,

Slides:



Advertisements
Similar presentations
Recommendations of the European Society of Skin Prevention (EUROSKIN) Source: Greinert et al. Eur J Cancer Prevention (2001) EUROCHIP-2 – Prevention domain.
Advertisements

REGULATING INDOOR TANNING WORLDWIDE Lawrence Green, MD, FAAD Board Certified Dermatologist Rockville, Maryland.
Compatibility Issues Regarding Agreement State Regulations for Portable Devices Containing RAM Sources Sean Chapel, President Presented at the 2006 Annual.
Proposed Amendments to FDA Sunlamp Product Performance Standard
Institutional Animal Care and Use Committee (IACUC)
Proposal for revising para of Regulation ECE R112 Annex 6 Zhang Heng P. R. China Informal document GRE (68th GRE, October 2012, agenda.
Indoor Tanning Association Dan Humiston President.
Strengthening the Medical Device Clinical Trial Enterprise
BASIC PRINCIPLES IN OCCUPATIONAL HYGIENE Day 4. LIGHTING AND NON-IONIZING RADIATION.
THE BED IS DEAD LEARN THE FACTS ABOUT UV AND THE HEALTH RISKS OF TANNING.
Public Health Issues Related to Mutually Conforming Labeling: CDRH Perspective Miriam C. Provost, Ph.D. Office of Device Evaluation Center for Devices.
IAEA International Atomic Energy Agency Responsibility for Radiation Safety Day 8 – Lecture 4.
What is ultraviolet radiation? Ultraviolet (UV) radiation is similar to visible light in all physical aspects, except that it does not enable us to see.
Sunlamps: Scientific Issues and Proposed Regulatory Revisions W. Howard Cyr, Ph.D. Senior Science Associate AEGIS Regulatory, P.A. Briefing for FDA, CDRH,
Pharmacology Application in Athletic Training Michelle Odai, MS, LAT, ATC, CSCS Florida International University.
Chapter 3 Preparing and Evaluating a Research Plan Gay and Airasian
CBER's policies on assay regulation: Definitions of assay performance characteristics Andrew I. Dayton, M.D., Ph.D. CBER.
Sun Protection Annie, Lizzie, Renee. Sun light contains ultraviolet radiation. While some exposure to the sun is beneficial for the production of vitamin.
Classification of HLA Devices FDA Introduction & Background Sheryl A. Kochman CBER/OBRR/DBA.
Radiation Occupational exposures and protection A. H. Mehrparvar, MD Occupational Medicine department Yazd University of Medical Sciences.
François Christiaens, L’Oréal Recherche,Clichy, France L’Oréal and Solar UV Radiation.
Copyright © 2005 SRI International Sun Protection Understanding the Danger.
Professional Vegetation Management NMVMA 11/20/2008 Pesticide Labeling Jeff Birk Regulatory Manager.
1 Southern California World Service Area Safety and Behavioral Requirements for Alateen Groups, Alateen Sponsors, and Al-Anon Members Involved in Alateen.
1 Amendments to the Sunlamp Perfomance Standard CDRH Working Group on Sunlamps.
Mammography Regulatory Issues Bruce Matkovich Radiation Safety Section Michigan Dept. Of Consumer & Industry Services.
Indoor Tanning Operator Compliance & Knowledge Robin L. Hornung, MD, MPH Pediatric Dermatologist, The Everett Clinic Clinical Associate Professor UW Division.
Unit 2: The Integumentary System
Artificial Tanning Joshua Langhorne, MD Janienne Kondrich, MD Community Pediatrics Legislative Advocacy Project.
Investigational New Drug Application (IND)
Medicaid EHR Incentive Program For Eligible Professionals Overview of the Proposed 2015 Modification Rule Kim Davis-Allen Outreach Coordinator
INDs : Does My Study Need One? Edith Paal UAMS Office of Research Compliance August 22, 2003.
GHS: Understanding Safety Data Sheets © 2012 Grainger Safety Services, Inc.
FDA GPSD Advisory Panel Mtg on Sunbed Safety Manny Karos B.S.UMD USC MS. Systems MgtSafety Retired FDA, CSO, Sunlamps Formerly Adjunct Faculty UMD, Systems.
1 CONSENSUS STANDARDS OIVD WORKSHOP April 22-23, 2003 Rockville MD Ginette Y. Michaud, M.D. OIVD.
TEPRSSC Meeting CDRH Update Lillian Gill October 1, 2003.
SKIN CANCER. How Cancer Occurs  Cancer develops only in cells with damaged genes (mutations).  If the genes that regulate the cell cycle are damaged,
Proposed Amendments to Enhanced Vapor Recovery Regulations November 18, 2004 Monitoring and Laboratory Division Air Resources Board California Environmental.
Prime Responsibility for Radiation Safety
Health and Safety and Cleanliness in Salons Public Protection Service
Humanitarian Use Devices September 23, 2011 Theodore Stevens, MS, RAC Office of Cellular, Tissue and Gene Therapies Center for Biologics Evaluation and.
Indoor Tanning Beds: A Serious Threat to Public Health William D. James, MD, FAAD President American Academy of Dermatology Association March 25, 2010.
Products to X-ray People for Security Presented to the : Technical Electronic Product Radiation Safety Standards Committee May 22, 2002.
1 Combination Products: Jurisdictional Issues MassMEDIC Presentation March 28, 2006 Janice Hogan, Esq. Partner Hogan & Hartson, LLP
Chapter 9.1 Notes Part 2. Infrared Radiation Infrared radiation has wavelengths of about one millimeter. Infrared radiation includes thermal radiation.
SunWiseSunWise JA 6-8 SunWiseSunWise JA Sun Safe Behaviors SunWise.
Medicaid Fee-for-Service: Prior Authorization Criteria & the Role of the DUR Board Charles Agte, Pharmacy Administrator Health Care Services June 19, 2013.
Rules for Supporting Part 803 and Part 806 Decision Making Page 1 Establishing Rules for: Medical Device Reports (803) & Correction and Removal Reports.
Tanning. Avae Marcello.
REGULATION OF COMBINATION PRODUCTS Mark A. Heller Wilmer Cutler Pickering Hale and Dorr LLP MassMEDIC Combination Product Program, March 28, 2006.
1 TEPRSSC Meeting Presentation October 1, 2003 D. L. Smith UVIR Research Institute [Ultraviolet, Visible and Infrared Radiation] Tucson, AZ.
General Regulatory Issues in the Development of Drugs Intended for Treatment of Chronic Illness Sharon Hertz, M.D. Medical Officer Division of Anesthetic,
Kelley Redbord, MD, FAAD Board Certified Dermatologist Dermatology and Dermatologic Surgery Group of Northern Virginia Vienna, Virginia March 25, 2010.
SKIN CANCER. How Cancer Occurs  Cancer develops only in cells with damaged genes (mutations).  If the genes that regulate the cell cycle are damaged,
What is Acid Rain and What Causes It?. How Do We Measure Acid Rain?
FDA Sunlamp Guidance Policies: Successfully Implemented Robert M. Sayre 1,2 John C. Dowdy 2 and and James G. Shepherd 3 1 Div Dermatology, Dept Medicine,
1 IND Applications for Academic Clinical Investigations John Marler, MD US Food and Drug Administration New Hampshire Avenue White Oak, MD
Personal Protective Equipment in General Industry
Hazard Communication Program
FDA’s IDE Decisions and Communications
How to Put Together an IDE Application
FDA Guidance for Industry and FDA Staff Summary of Public Notification of Emerging Postmarket Medical Device Signals (“Emerging Signals”) Effective: December.
Hazard Communication Program
HL7 International January Working Group Meeting Health Care Device WG
ULTRAVIOLET RAYS By: Brenton edwards.
Linda M. Chatwin, Esq. RAC Business Manager, UL LLC
TRTR Briefing September 2013
Food Safety and Regulatory Measures 2016
Regulatory Perspective of the Use of EHRs in RCTs
Presentation transcript:

Sunlamps: Scientific and Regulatory Issues W. Howard Cyr &Sunlamp Working Group. Center for Devices and Radiological Health Regulatory Meeting, Baltimore, August 16, 2001

Background TEPRSSC - Two years ago – presented 5 possible amendments –Our assessment in 2002 – these were “non-controversial” –Reality – “major concerns from affected industry

“ Controversial” proposals Place existing recommended exposure schedule into the regulations Use Non-melanoma action spectrum in addition to erythemal action spectrum Exposure schedules and action spectra are subjects of research and standards development

Interactions with stakeholders At the suggested of TEPRSSC –Meeting on September 13, 2000 to discuss “controversial issues” –Meeting on February 7 and 8, 2002 to discuss lamp compatibility

Exposure Schedules CDRH convinced that more research was necessary on recommended exposure schedules –Measurement techniques of skin sensitivity to UV - >100 human subjects –New project on doses for producing and maintaining tans

Action spectra Debate over the use of NMSC action spectrum Debate over annual limits Effect on industry because of “cancer” scares

Four Revised Proposals Revised warning label Inclusion of label into catalogues, specification sheets, and descriptive brochures Significant modification means re- certification as a “manufacturer” Revised specification for eyewear

Rationale for Revised Proposals Clearer, “user friendly” warning label Warnings in home-use products and in advertisements (new) Requirements of a “manufacturer” in Performance Standard, per se Eyewear requirement consistent with international consensus standards

Existing Warning Label 1 DANGER-Ultraviolet radiation. Follow instuctions. Avoid overexposure. As with natural sunlight, overexposure can cause eye and skin injury and allergic reactions. Repeated exposure may cause premature aging of the skin and skin cancer.

Existing Warning Label 2 WEAR PROTECTIVE EYEWEAR. FAILURE TO MAY RESULT IN SEVERE BURNS OR LONG-TERM INJURY TO THE EYES. Medications or cosmetics may increase your sensitivity to the ultraviolet radiation.

Existing Warning Label 3 Consult physician before using sunlamp is you have a history of skin problems or believe yourself especially sensitive to sunlight. If you do not tan in the sun, you are unlikely to tan from use of this product.

Revised Warning Label WARNING - Ultraviolet radiation may cause: –injury to the eyes and skin –skin aging –skin cancer. Read instructions carefully. Wear protective goggles provided. Certain medicines and cosmetics may increase sensitivity to ultraviolet radiation

Warning labels FDA proposes: …in all catalogs, specifications sheets, and descriptive brochures and any other purchasing information pertaining to each sunlamp product and ultraviolet lamp, a legible reproduction of the warning statement required by 21 CFR (d)(1)(I) shall be affixed

Manufacturer “The modification of a sunlamp product, previously certified under 21 CFR , by any person engaged in the business of manufacturing, assembling, or modifying sunlamp products shall be construed as manufacturing under the act if...

Manufacturer 2 “… the modification affects any aspect of the product’s performance or intended function(s) for which this section (21 CFR ) have an applicable requirement. The manufacturer who performs such modification shall recertify and re-identify the product in accordance with 21 CFR and ”

Eyewear Current FDA: “the spectral transmittance shall not exceed a value of over the wavelength region 200 to 320 nm, and a value of 0.01 for 320 to 400 nm, and shall be sufficient over the wavelength region > 400 nm to enable user to see clearly enough to reset the timer”

Eyewear Proposed: –same UV limits –for visible region, a more quantitative definition: “the luminous transmittance shall not be less than 1% over the 400 to 550 nm wavelength region” –describe measurement techniques

Other Issues - Update Replacements Lamps - absolute method of determining ‘compatibility’ (should be ready for next TEPRSSC) Discussion issues –Revised Recommended Exposure Schedules –Revised definition of MED –CIE Action Spectra for Erythema and NMSC –Annual limits

Summary Present 4 proposed amendments at May 22, 2002 TEPRSSC meeting Add Lamp Compatibility amendment at Fall, 2002 TEPRSSC meeting Continue evaluations and laboratory studies on other issues Work on international harmonization